Literature DB >> 9510444

Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.

H Koyanagi1, Y Nakamura, H Yanagawa.   

Abstract

Giant aneurysms are the most serious issue of patients with Kawasaki disease (KD). To clarify risk factors for these giant aneurysms, we conducted a matched case-control study. Among the patients reported in nationwide surveys, 117 patients with giant aneurysms had an unequivocal new diagnosis and presented at the treatment center within 9 d of illness. We obtained clinical information on admission of about 69 patients (case) from the treatment centers. One control was selected for each case, an age- and sex-matched patient without coronary involvement, reported from the same treatment center at about the same time as the case, and we obtained the same clinical information about controls. Fourteen variables were analysed with a conditional logistic regression model: body temperature, hematocrit, hemoglobin, numbers of leukocyte and platelets, concentrations of serum albumin, globulin, total cholesterol, sodium, potassium and chloride, erythrocyte sedimentation rate, C-reactive protein and alanine aminotransferase activity. After adjustment for age, duration of illness before admission and use of intravenous gamma globulin therapy, C-reactive protein [odds ratio (OR)=1.142, 95% confidence interval (CI) 1.054-1.237], alanine aminotransferase activity (OR=1.008, 95% CI 1.002-1.014), serum sodium concentration (OR=0.877, 95% CI 0.770-0.999) and serum potassium concentration (OR=0.319, 95% CI 0.124-0.822) were significantly related to the risk for giant aneurysms. Further analyses with these four explanatory variables revealed that C-reactive protein (OR=1.159, 95% CI 1.022-1.315) and serum potassium concentration (OR=0.222, 95% CI 0.052-0.948) met the significant level. Thus, the values for serum C-reactive protein and potassium are independent risk factors for the development of the giant aneurysms of Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510444     DOI: 10.1080/08035259850157831

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Serum sodium levels in patients with Kawasaki disease.

Authors:  H Muta; M Ishii; K Egami; S Hayasaka; Y Nakamura; H Yanagawa; T Matsuishi
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

2.  Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.

Authors:  Yue Peng; Qiongfei Pei; Siqi Feng; Ya Su; Ruixi Liu; Qijian Yi; Pengfei Guo
Journal:  Clin Exp Med       Date:  2019-09-03       Impact factor: 3.984

3.  Serum alanine aminotransferase level and intravenous immunoglobulin resistance in patients with kawasaki disease.

Authors:  Hiroya Masuda; Ryusuke Ae; Taka-Aki Koshimizu; Koki Kosami; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Yosikazu Nakamura
Journal:  Clin Rheumatol       Date:  2022-07-07       Impact factor: 3.650

4.  Predicting Intravenous Immunoglobulin Resistance Among North American Children Hospitalized With Kawasaki Disease.

Authors:  Jasdip Singh; Arthur Chang; Nicholas M Fusco; Mark Hicar
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26

5.  Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in kawasaki disease.

Authors:  Goh-Woon Lim; Mina Lee; Hae Soon Kim; Young Mi Hong; Sejung Sohn
Journal:  Korean Circ J       Date:  2010-10-31       Impact factor: 3.243

6.  Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.

Authors:  Masanari Kuwabara; Mayumi Yashiro; Kazuhiko Kotani; Satoshi Tsuboi; Ryusuke Ae; Yosikazu Nakamura; Hiroshi Yanagawa; Tomisaku Kawasaki
Journal:  J Epidemiol       Date:  2015-01-10       Impact factor: 3.211

7.  Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.

Authors:  Ming-Yu Liu; Hsin-Min Liu; Chia-Hui Wu; Chin-Hao Chang; Guan-Jr Huang; Chun-An Chen; Shuenn-Nan Chiu; Chun-Wei Lu; Ming-Tai Lin; Luan-Yin Chang; Jou-Kou Wang; Mei-Hwan Wu
Journal:  BMC Pediatr       Date:  2017-06-06       Impact factor: 2.125

8.  Identification of Diagnostic Gene Markers and Immune Infiltration in Systemic Lupus.

Authors:  Hongtao Hu; Chengsong He
Journal:  Comput Math Methods Med       Date:  2022-05-10       Impact factor: 2.809

9.  Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever.

Authors:  Kyung-Yil Lee; Ji-Whan Han; Ja-Hyun Hong; Hyung-Shin Lee; Joon-Sung Lee; Kyung-Tai Whang
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.